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Bright, near infrared emitting PLGA–PEG dye-
doped CN-PPV nanoparticles for imaging
applications
Evren Kemal,a Thais Fedatto Abelha,b Laura Urbano,b Ruby Peters,a Dylan M. Owen,a
P. Howes,a Mark Green*a and Lea Ann Dailey*b
Conjugated polymers are of interest as optical imaging probes for clinical diagnostic applications. However,
clinical translation requires not only an excellent optical performance, but also an established safety proﬁle
and scalable manufacturability. Taking these factors into account, a self-assembling nanoparticle system
was designed utilising the amphiphilic diblock copolymer, PLGA–PEG, to encapsulate the red-emitting
conjugated polymer, CN-PPV. Encapsulation of decreasing amounts of CN-PPV (50% to 5% w/w) resulted
in a decrease in nanoparticle size and an increase in optical performance (quantum yield% 40%). All
systems were colloidally and optically stable over 60 days at 37 C. Optimized systems were then used to
encapsulate small amounts (0.5–0.8% w/w) of small molecule near-infrared dyes, NIR680 and NIR720,
generating systems with shifted emission peaks >700 nm. Optimised PLGA–PEG micelles containing 5%
CN-PPV and 0.5% NIR720 showed enhanced characteristics, such as a high product yield (>90%), a narrow
emission peak at 720 nm, a high quantum yield of 45%, a small hydrodynamic diameter (104 nm), and an
enhanced cytocompatibility proﬁle compared to other systems tested in this study, i.e. no reduction in cell
viability and negligible impairment of mitochondrial acitivity at higher concentrations.
Introduction
In recent years, conjugated polymer nanoparticles (CPNs), also
known as semiconducting polymer nanoparticles and polymer
dots (P-dots), have emerged as a novel class of extraordinarily
bright photoluminescent probes with many applications in
bioimaging and diagnostics.1–10 Near-infrared (NIR) uores-
cence imaging in the 700–800 nm wavelength range is very
attractive for real time in vitro and in vivo applications as tissue
penetration is at its deepest with minimal auto-uorescence.2,9
Small molecule NIR dyes, such as the FDA-approved indoc-
yanine green11 are currently used in uorescence imaging and
assays; however, the majority of these agents suﬀer from limi-
tations such as low brightness, insuﬃcient photostability, and
a small Stokes shi.1–5
Inorganic semiconductor nanocrystal quantum dots (Qdots)
have been developed as NIR probes as they oﬀer a signicantly
higher photostability and brightness compared to small mole-
cule NIR dyes. However, toxicity and the disruption of shielding
surface modication are critical concerns for their biological
applications.2,3,12 NIR-emitting CPNs, in contrast, oﬀer a high
brightness, good photostability, and minimal toxicity to
biological cells and tissues.1–5 To achieve emission in the NIR
region, CPNs have been manufactured according to multiple
strategies, which all aim to produce nanoparticles with
enhanced optical performance.1–11 For example, low molecular
weight, hydrophobic NIR dyes have been encapsulated within
a CPN core resulting in quenching of visible emission of the
conjugated polymer with distinct NIR emission2 or multiple
cascading light emitting polymers have been produced, which
transfer the energy more eﬃciently to the dopant dye.4 Disad-
vantages of such systems, however, include low CPN yields, dye
leakage from the construct,7 poor stability in various environ-
ments and broader emission spectra compared with Qdots or
NIR dyes.4,5 Development of narrow, bright NIR CPNs remains
an important target for a variety of biological applications.
As biomaterials, nanodiagnostics require functionality in
various physiological environments and tissues.13–18 To promote
translation of NIR-emitting CPNs towards clinical applications,
this work focussed on self-assembling systems utilising the
amphiphilic, biodegradable diblock copolymer, poly(lactic-co-
glycolic acid)polyethylene glycol (PLGA–PEG),19 as a matrix for
encapsulation of the red-emitting conjugated polymer, poly(2,5-
di(hexyloxy) cyanoterephthalylidene) (CN-PPV). The advantages
of embedding CN-PPV within self-assembling PLGA–PEG poly-
mer micelles include an increase in CPN yield during manu-
facture and provision of a stable PEGylated surface, which will
increase CPN circulation times, reduce undesired protein
corona formation or liver accumulation due to in vivo clearance
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by the mononuclear phagocytic system.19–22 Furthermore, the
biodegradable nature of the system20,21 may present a potential
mechanism for in vivo clearance and elimination of systemically
administered nanodiagnostics.
In addition to the basic system comprised of PLGA–
PEG : CN-PPV (Fig. 1), two low molecular weight NIR dyes,
NIR680 and NIR720, were incorporated into the nanoparticle
core to exploit Fo¨rster resonance energy transfer (FRET) and
shi emission proles towards longer wavelengths. The
resulting systems were characterised in-depth with regard to
physicochemical and optical properties prior to use in cell-
based assays to assess their performance as cellular imaging
agents and biocompatibility.
Experimental
Materials
Poly(2,5-di(hexyloxy)cyanoterephthalylidene) (CN-PPV), NIR680,
NIR720, poly(ethylene glycol) methylether-block-poly(lactide-co-
glycolide) copolymer with 50 : 50 ratio of lactide/glycolide (PEG5
kDa–PLGA55 kDa), ultrapure water and tetrahydrofuran (THF
ReagentPlus®, $99.9%) were purchased from Sigma-Aldrich
and used as received.
CPN manufacture
In a typical example synthesis, 5 mg CN-PPV was dissolved in 10
mL THF (0.5 mg mL1) followed by sonication for 10 minutes. 1
mL of this stock solution was added to 10 mg of PLGA–PEG (60
K). In a separate ask, 1 mg of NIR720 was dissolved in 10 mL
THF, 25 microlitres of which were then added to the CN-PPV/
polymer stock solution. The nal stock solution was then
added to 5 mL ultrapure water, which was sonicated for 15
minutes and le stirring for 24 hours to facilitate complete
evaporation of THF. Loss of water was compensated by read-
justment to 5 mL. The resultant CPN suspensions had a nal
concentration of ca. 100 mg mL1 CN-PPV with diﬀerent total
solids concentrations (Table 1).
Particle size and zeta potential
Particle hydrodynamic diameter was assessed by nanoparticle
tracking analysis (NTA; NanoSight® LM10, Malvern Instruments,
UK) tted with a blue laser (60 mW at 405 nm). CPN suspensions
(100 mL) were diluted in 5 mL deionised water and 0.3 mL of the
dilute sample was passed through the ow chamber of the
NanoSight® unit. The C11440-5B camera was set to 20 capture
magnication with a 250 gain (a.u.). NTA 2.3 analysis soware
was used to generate three 30 second scripts, which provided the
average and modal hydrodynamic diameter, standard deviation
and total concentration of the suspension. For selected systems,
CPNs were stored at 37 C in a dark incubator and the particle
size measured at regular intervals over a time period up to 60
days. The zeta potential was measured using a Nanosizer
(Nanosizer, Malvern Instruments, UK) in 10 mM NaCl at 25 C.
A range of CPNs containing NIR680 or NIR720 were prepared
using either a 1 : 1 or 20 : 1 ratio of PLGA–PEG : CN-PPV. NIR720
was dissolved in THF (0.1 mg mL1) and the appropriate volumes
were added to the PLGA–PEG : CN-PPV solution in THF so that
nal dye concentrations ranging from 0.25, 0.5 or 0.75% (mass dye
permass CN-PPV) were achieved. The CPNmanufacture proceeded
as described above. NIR680, which is insoluble in THF, was dis-
solved in ethanol (0.1 mgmL1) and diﬀerent volumes were added
to the 5 mL aqueous phase to achieve concentrations ranging
between 0.4, 0.8 or 1.2% (mass dye per mass CN-PPV). Subse-
quently, the polymer solution in THFwas injected into the aqueous
phase and CPN preparation proceeded as described above.
Optical characterisation
Photoluminescence (PL) emission scans were measured on
a luminescence spectrometer (LS50B, Perkin-Elmer Inc., USA
Fig. 1 The proposed structure of the self-assembling CPN comprised of either 100% CN-PPV, 95% PLGA–PEG with 5% CN-PPV or 95% PLGA–
PEG with 5% CN-PPV and small amounts of encapsulated NIR680 and NIR720 (left to right respectively). The image on far right shows the red
emission of PLGA–PEG : CN-PPV nanoparticles under excitation from a 405 nm laser.
Table 1 Composition, mass ratios and total solids concentrations of
the self-assembling nanodiagnostics systems
PLGA–PEG : CN-PPV
ratio (system abbreviation)
PLGA–PEG
(% m m1)
CN-PPV
(% m m1)
Total solids
(mg mL1)
0 : 1 0 100 100
1 : 63 1.6 98.4 101.6
1 : 6 16.6 83.4 116.6
1 : 3 33.3 66.7 133.3
1 : 1 50 50 200
20 : 1 95 5 2100
1 : 0 100 0 2100
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using the following settings: 470 nm excitation wavelength,
emission slit width of 5 nm, excitation slit width of 4 nm and
emission scan from 500 to 800 nm. For selected systems, CPNs
were stored 37 C in a dark incubator and the PL emission scan
measured at regular intervals over a time period up to 60 days.
Absorption spectroscopy was performed on a Perkin-Elmer
Lambda 800 UV/vis spectrophotometer. An absolute quantum
yield measurement system (C9920-02G; Hamamatsu) was used
to record the QY of samples. An integrating sphere capable of
nitrogen gas ow and a CCD spectrometer for detecting the
whole spectral range simultaneously. The following setting
where used with an excitation light source at 480 nm, with
a bandwidth of 5–7 nm. The spectra were averaged from 20
repeat recordings.
Transmission electron microscopy
Transmission electron microscopy (TEM) was performed on an
FEI Tecnai 20 at 200 kV for high resolution imaging. Samples
were drop cast and dried on carbon lm copper grids. Particle
size analysis was conducted using Image J soware.
CPN interactions with HeLa cells
HeLa cells (American Type Culture Collection-ATCC CCL-2, cat.
no. CCL-2) were cultured as adherent monolayers in Dulbecco's
Modied Eagle Medium (DMEM, cat. no. D5796, Sigma) sup-
plemented with 10% heat inactivated foetal calf serum (FCS,
cat. no. F2442, Sigma), on a sterile 8 square well microplate.
Cells were cultured at 37 C, 5% CO2 in a humidied incubator
at 0.3  106 cells per well. Four CPN suspensions were studied:
(1) CN-PPV alone (0 : 1) as a control, (2) PLGA–PEG : CN-PPV
(1 : 1), (3) PLGA–PEG : CN-PPV with NIR680 (1 : 1 (680)) and
(4) PLGA–PEG : CN-PPV with NIR720 (1 : 1 (720)). CPN suspen-
sions (150 mL; equivalent to 30 mg total solids and 15 mg CN-PPV
per well) were added to 150 mL cell culture media and incubated
for 1 h with cells. Following incubation, cells were washed six
times with warm phosphate-buﬀered saline (pH 7.0) and
imaged live every 5 seconds for 5 min with a Nikon A1R +
confocal using a 20 objective lens of numerical aperture 0.75
combined with a Nikon Ti-E inverted microscope system. A
488 nm argon ion laser was used for excitation and emission
was collected in two channels: 570–620 nm (visible red) and
663–738 nm (NIR). Corrected Total Cell Fluorescence was
calculated using Image J soware.
CPN biocompatibility with THP-1 cells
A second cell line, the human monocyte-derived macrophage
cell line, THP-1 (American Type Culture Collection-ATCC
TIB202 monocytic leukaemia cells), were used to assess dose-
dependent biocompatibility proles of selected CPN systems.
THP-1 cells were cultured and diﬀerentiated with 10% foetal
bovine serum (FBS, obtained from Sigma, product number
F7524, batch number BCBR1178V), in 96 well plates. Five
suspensions were studied: (1) CN-PPV alone (0 : 1) as a control;
(2) PLGA–PEG nanoparticles without CN-PPV (1 : 0) as a control;
(3) PLGA–PEG : CN-PPV (20 : 1); (4) PLGA–PEG : CN-PPV with
NIR680 (20 : 1 (680)) and (5) PLGA–PEG : CN-PPV with NIR720
(20 : 1 (720)). To assess a representative CPN dose range (0.03–
300 mg mL1 total solids) CPN suspensions had to be concen-
trated to 1.5 mg mL1 using centrifugal ltration (MWCO: 100
kDa; Amicon® Ultracel-100). It was noted that 1 : 1 systems
aggregated during the concentration process, therefore all
systems were produced at a PLGA–PEG : CN-PPV ratio of 20 : 1.
CPN suspensions (60 mL; 1.5 mg mL1) were added to 240 mL
cell culture media and eight serial dilutions decreasing in
increments of 0.33 concentration were produced. Negative
controls consisted of 100% medium and medium diluted with
16 and 6% deionized water. Cells were incubated for 24 h with
200 mL of CPN suspensions in media and negative controls.
Aer 24 h, carbonyl cyanide 4-(triuoromethoxy)phenyl-
hydrazone (FCCP; 200 nM), a mitochondrial decoupler and
positive control, was incubated in selected wells for 15 min. All
wells were then incubated at 37 C for 30 min with a dye cocktail
(100 mL) containing Mitotracker Red, Hoechst 33342 and
ImageItDead dyes (600 nM, 32 mM and 50 nM, nal concen-
tration), followed by a two-fold wash step with warm phosphate
buﬀered saline (PBS) and xation with PBS containing 4%
paraformaldehyde and 5% sucrose. Finally, CellMask Deep Red
(2 mg mL1 nal concentration) was added to the cells and
incubated for 120 min at room temperature followed by storage
at 4 C until imaging. Immediately prior to imaging, cells were
washed twice in PBS and 100 mL fresh PBS was added to each
well.
Plates were imaged on the IN Cell Analyzer 6000 (INCA6000;
GE Healthcare) using a 40/60 magnifying objective acquiring
12 random elds per well. Images were acquired in the UV
channel at 405 nm excitation and 455/50 nm and 682/60 emis-
sion lters, in the FITC channel at 488 nm excitation and 524/
48 nm emission lters, in the dsRed channel at 561 nm exci-
tation and 605/52 nm emission lters and in the Cy5 channel at
642 nm excitation and 682/60 nm emission lters. Automated
image analysis was conducted with the IN Cell Developer 1.9
soware (GE Healthcare) using custom-developed analysis
protocols.
Statistical analysis
Statistical comparisons were conducted using ANOVA via Graph
Pad Prism (San Diego, CA). Values were considered signicant
when *p < 0.05 **p < 0.01, ***p < 0.001.
Results
CPNs manufactured with increasing PLGA–PEG content
exhibited hydrodynamic diameters ranging from 110–140 nm
(Fig. 2A). Inclusion of PLGA–PEG led to a signicant increase in
hydrodynamic diameter compared to nanoparticles comprised
of 100% CN-PPV (0 : 1). The diﬀerences in hydrodynamic
diameters measured between CN-PPV with and without PLGA–
PEG were attributed primarily to presence of the 5 kDa PEG
layer on the particle surface. Electron microscopy (TEM) was
used to further characterise diﬀerences between CPNs consist-
ing of CN-PPV alone (0 : 1) and PLGA–PEG : CN-PPV (1 : 1)
(Fig. 2B). TEM images of CN-PPV 0 : 1 control samples generally
This journal is © The Royal Society of Chemistry 2017 RSC Adv., 2017, 7, 15255–15264 | 15257
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showed smaller and less polydisperse particle sizes compared
with PLGA–PEG systems, supporting the trends observed with
NTA analysis. Both systems were also stable in size over 60 days
(Fig. 2D).
The optical properties of CN-PPV CPNs with and without
PLGA–PEG were also characterised (Fig. 3). Fig. 3A shows the
emission intensity of 0 : 1, 1 : 3 and 1 : 1 systems as a function
of CN-PPV concentration. It can be seen that increasing the
PLGA–PEG in the system increased the emission intensity and
reduced quenching at higher concentrations. Normalised
absorption and emission spectra of 0 : 1 and 1 : 1 showed that
the inclusion of PLGA–PEG had no eﬀect on the CN-PPV emis-
sion proles (Fig. 3B). Further, the PL emission proles of CPN
suspensions with equivalent CN-PPV content displayed
a remarkable similarity over a 60 day time period when incu-
bated in aqueous media at 37 C (Fig. 3C and D).
Incorporation of NIR680 and NIR720 into PLGA–PEG : CN-
PPV CPNs
NIR680 and NIR720 absorb at 680 and 700 nm with emission
maxima at 707 and 720 nm, respectively. It was thus hypothe-
sized that inclusion of these dyes within the PLGA–PEG : CN-
PPV systems would generate CPNs with bright, narrow emis-
sion peaks >700 nm. Three diﬀerent concentrations of each NIR
dye were incorporated into PLGA–PEG : CN-PPV (1 : 1) systems
to determine the optimal amount of NIR dye (Fig. 4A and B). From
this data, it was concluded that 0.8%NIR680 and 0.5%NIR720 (%
mm1 with regard to CNPPV) was optimal and would be used for
all further studies. Normalised absorption and PL emission
spectra comparing PLGA–PEG : CN-PPV (1 : 1) with 1 : 1 systems
containing NIR680 and NIR720 (Fig. 4C) revealed that inclusion of
the dyes shied emission maxima to higher wavelengths as
hypothesized, albeit with diﬀerent levels of energy transfer
(FRET). Systems incorporating NIR680 exhibited bimodal spectra
with one peak at 630 nm characteristic of CN-PPV emission and
a second peak at 707 nm characteristic of the NIR680 emission
prole, thus indicating that incomplete energy transfer was
occurring between the conjugated polymer and the NIR dye. This
prole might also be indicative of an incomplete encapsulation of
the more hydrophilic NIR680 compound. In contrast, 1 : 1 (720)
showed a near complete energy transfer the polymer and dye, as
shown by the disappearance of the CN-PPV peak and the emer-
gence of narrow peak (23 nm width) with a maximum at 720 nm.
The optical stability was also characterised over a 14 day period of
incubation in the dark at 37 C (Fig. 4D) revealing that the 1 : 1
(720) system was extremely stable, while the 1 : 1 (680) system
showed slightly more variability, although no indication of
signicant quenching over time.
The hydrodynamic diameters derived from NTA (Fig. 5A)
show that incorporation of both NIR dyes resulted in
Fig. 2 (A) Mean hydrodynamic diameters (NTA) as a function of PLGA–PEG content. Values represent the mean  standard deviation of n ¼ 3
CPN batches. (B) Representative TEM images of CN-PPV (0 : 1) and PLGA–PEG : CN-PPV (1 : 1); scale bar 500 nm. (C) TEM particle size
distribution of CN-PPV (0 : 1) and PLGA–PEG : CN-PPV (1 : 1). (D) Colloidal stability of aqueous 0 : 1 and 1 : 1 systems stored in the dark at 37 C
over 60 days. Values represent the mean  standard deviation of n ¼ 3 batches (NTA).
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signicantly smaller particles sizes compared to 1 : 1 systems
without dye encapsulation (p < 0.001). Furthermore 1 : 1 (680)
was signicantly smaller the 1 : 1 (720) (p < 0.001). The analysis
of particle size distributions from the TEM images (Fig. 5B and
C) conrmed this trend. Colloidal stability studies showed that
all systems were stable over 14 days when incubated at 37 C in
the dark (Fig. 5D).
Performance as cell imaging agents and biocompatibility
To assess the brightness of selected systems within a biological
environment, HeLa cells were incubated for 1 h with low
concentrations (equivalent to 15 mg mL1 CN-PPV diluted in cell
culture medium) of 0 : 1, 1 : 1, 1 : 1 (680) and 1 : 1 (720) CPNs.
Confocal microscopy images were acquired (Fig. 6A) using
a visible red lter (570–620 nm) and an NIR band lter (663–738
nm). Based on the optical and physicochemical characteristics
of the systems, it was hypothesized that the highly electroneg-
ative CN-PPV nanoparticles (0 : 1; zeta potential  70 mV)
would show both a high cell internalisation rate23 and strong PL
in the visible red channel, but not the NIR channel. In contrast,
the peglylated surface coating of the three remaining systems
was hypothesized to reduce particle internalisation23 resulting
in a lower cell association and lower PL in both channels. Based
on the emission proles in Fig. 5, it was postulated that the 1 : 1
(680) would be visible in both channels, while the 1 : 1 (720)
CPNs should be detected primarily in the NIR channel.
Images from the visible red channel (Fig. 6A le panel) show
that nearly all HeLa cells depicted were associated with CPNs,
either through particle internalisation or surface adsorption. As
expected both the 1 : 1 (680) and 1 : 1 (720) systems, but not the
0 : 1 or 1 : 1 systems could be visualised in the NIR channel
(Fig. 6B, right panel). It was interesting to observe that the
presence of PEG on the surface of the 1 : 1 systems did not
appear to reduce particle association with HeLa cells (Fig. 6C).
This could indicate that the stealth surface coating is not
suﬃciently dense in order to prevent particle interactions with
cells. The other unexpected observation was the relatively
strong signal of the 1 : 1 (720) in the visible red channel
compared with the NIR channel. As all microscope settings were
adjusted to reduce cell autouorescence to a minimum, the
signal is most likely to be derived from the residual CN-PPV
signal in the 1 : 1 (720) system (Fig. 4B).
In vitro biocompatibility studies were also performed in
order to assess cytotoxicity over a wide range of total solids
concentrations (0.01–300 mg mL1). To dilute the systems at the
Fig. 3 (A) PL of 0 : 1, 1 : 3 and 1 : 1 as a function of CN-PPV concentration following excitation at 470 nm. (B) Normalised absorption and
emission proﬁles of 0 : 1 and 1 : 1 CPNs. PL emission spectra of CN-PPV (0 : 1) CPNs (C) and PLGA–PEG: CN-PPV (1 : 1) CPNs (D) as a function of
time (t ¼ 0, 35, 42, 60 days) when incubated at 37 C. For stability studies, CPN suspensions were measured at an equivalent CN-PPV
concentration 6.25 mg mL1.
This journal is © The Royal Society of Chemistry 2017 RSC Adv., 2017, 7, 15255–15264 | 15259
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
7 
M
ar
ch
 2
01
7.
 D
ow
nl
oa
de
d 
on
 0
9/
11
/2
01
7 
11
:5
4:
43
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Fig. 4 PL spectra of (A) PLGA–PEG : CN-PPV 1 : 1 systems containing 0.4–1.2% NIR680 and (B) PLGA–PEG : CN-PPV 1 : 1 systems containing
0.25–0.75% NIR720. (C) Normalised absorbance and emission spectra of 1 : 1, 1 : 1 (680) and 1 : 1 (720). (D) Optical stability of 1 : 1, 1 : 1 (680) and
1 : 1 (720) over 14 days at a constant CN-PPV concentration of 6.25 mg mL1.
Fig. 5 (A) Hydrodynamic diameters of 0 : 1, 1 : 1, 1 : 1 (680) and 1 : 1 (720). (B) TEM images of 1 : 1 (680) and 1 : 1 (720), scale bar ¼ 500 nm. (C)
TEM size distribution proﬁles of 1 : 1 (680) and 1 : 1 (720). (D) Size stability over 14 days of 1 : 1 (680) and 1 : 1 (720) as measured by NTA. Values
represent the mean  standard deviation of n ¼ 3 nanoparticle batches.
15260 | RSC Adv., 2017, 7, 15255–15264 This journal is © The Royal Society of Chemistry 2017
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requisite nal concentration, stocks of 1 mg mL1 were
prepared using centrifugation ltration. Despite the application
of relatively low centrifugal forces, 0 : 1 and all 1 : 1 systems
aggregated irreversibly during centrifugation. Further optimi-
sation studies conrmed that the use of a 20 : 1 PLGA–
PEG : CN-PPV ratio produced systems which were stable under
centrifugal force and at high concentrations, therefore, all
further cell studies were performed with 20 : 1 systems.
Table 2 lists important physicochemical and optical prop-
erties of three 20 : 1 systems produced for this phase of the
study. Increasing the PLGA–PEG : CN-PPV ratio to 20 : 1 showed
a signicant decrease in size (20 nm) compared to 1 : 1 ratio (p
< 0.001). Zeta potential measurements conrmed that the
surface of the 20 : 1 systems was more consistently covered with
a non-ionic PEG layer, as denoted by the substantial decrease in
zeta potential compared to CN-PPV nanoparticles without
PLGA–PEG (0 : 1), as well as compared to 1 : 1 systems (43–55
mV). Interestingly, the 20 : 1 PLGA–PEG : CN-PPV systems had
a higher absolute quantum yield compared with CN-PPV alone.
The 20 : 1 system incorporating the NIR720 had the highest
quantum yield of 45% and a very narrow emission peak. Most
organic small molecule NIR dyes typically have a quantum
below 1%.24
The cell line, THP-1 monocytes diﬀerentiated with PMB into
a macrophage phenotype, were used in conjugation with a high
content analysis assay to assess cell viability, mitochondrial
activity and CPN-cell association (Fig. 7). Negative controls
consisted of untreated cells, medium diluted with 16 or 6%
distilled water and PLGA–PEG micelles without CN-PPV (1 : 0),
while FCCP, a mitochondrial uncoupler, was used as a positive
control.
Incubation of the cells for 24 h with ve micellar systems
(0 : 1, 20 : 1, 20 : 1 (680), 20 : 1 (720) and 1 : 0) showed no
signicant decrease in cell numbers caused by nanoparticle-
induced necrosis (Fig. 7A). However, at concentrations of 100
mg mL1 and above, systems containing PLGA–PEG showed
signicant increases in the percentage of the cell population
with impaired mitochondrial activity (Fig. 7B). This behaviour
appeared to be independent of the CN-PPV content and was
most prominent in the 20 : 1 (680) system. Interestingly, the
20 : 1 (720) system appeared to have very little impact on
mitochondrial health. The decrease in mitochondrial activity in
the presence of the 20 : 1 (680) system might be explained by
two factors. First, ethanol was used in the preparation of this
system and traces may have remained in the structure aer
Fig. 6 CPN association with HeLa cells. (A) Representative confocal
images of HeLa cells following 1 h incubation with 0 : 1, 1 : 1, 1 : 1 (680)
and 1 : 1 (720) systems (15 mg mL1 CN-PPV). Cells are visualised using
a visual red band ﬁlter (570–620 nm, left panel) and a NIR band ﬁlter
(668–730 nm, right panel). (B) The corrected total cell ﬂuorescence
(CTCF) was calculated using ImageJ software from n ¼ 3 diﬀerent
images.
Table 2 CPN hydrodynamic diameter (HD) as measured by NTA and
zeta potential (ZP) values. Results are comprised of the mean 
standard deviation of n ¼ 3 batches. Absolute quantum yield (QY) and
full width at half maximum (FWHM) values are provided for all systems
excited at 500 nm (n ¼ 1 batch)
CPN system HD (nm) ZP (mV) QY (%) FWHM (nm)
0 : 1 110  1.53 77.1  0.6 37 154
20 : 1 122.7  3.5 29.2  0.4 40 149
20 : 1 (680) 96.5  2.1 30.5  0.4 38 152
20 : 1 (720) 103.5  2.1 28.5  0.4 45 23
This journal is © The Royal Society of Chemistry 2017 RSC Adv., 2017, 7, 15255–15264 | 15261
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evaporation of the majority of the solvent, causing cytotoxicity.
Secondly, the PL emission proles of systems containing
NIR680 suggest that the dye was not fully encapsulated in the
polymer micelle core (in contrast to the more hydrophobic
NIR720 dye). Thus, unencapsulated NIR680 may have a delete-
rious impact on mitochondrial activity, independent of the
polymer micelles. As the performance of the CPN systems
containing NIR720 was superior to the systems containing
NIR680, further studies investigating the encapsulation eﬃ-
ciency of NIR680 and the residual ethanol content were not
pursued.
Following excitation at 488 nm and image capture using
a red emission lter a red emission lter (682/60), the associa-
tion of systems containing CN-PPV with the THP-1 cells was
analysed. Similar to the observations made with the HeLa cell
line, the pegylated 20 : 1 systems appeared to have the same cell
association rate as the nanoparticles consisting of 100% CN-
PPV, indicating that the stealth coating did not substantially
reduce particle–cell interactions. At concentrations above 1 mg
mL1, both the 20 : 1 (680) and the 20 : 1 (720) systems had
a signicantly lower uorescence intensity per well (P < 0.05).
However, without quantication of the CN-PPV content within
the cell layer, which was not performed due to interference from
the other uorescent dyes used in the high content analysis, it
cannot be ascertained whether the two systems had a lower
cellular uptake or the PL was impacted by the intracellular
environment. Further studies using the 20 : 1 (720) are currently
ongoing to assess this in greater detail.
Discussion
Fluorescent nanoparticles have potential applications in many
biological and medical elds. The main types of uorescent
nanomaterials can be classed as uorescent dye nanoparticles,
inorganic nanocrystals also known as quantum dots (Qdots) or
conjugated polymer nanoparticles (CPNs), also known as uo-
rescent polymer nanoparticles (Pdots).25 Although all these
nanoparticle types have their own constraints, both Qdots and
CPNs oﬀer signicant increases in brightness and stability
compared to dyes.1–5Qdots can be synthesized inmany diﬀerent
Fig. 7 (A) THP-1 cell count per well following incubation for 24 h with various treatments. (B) Percentage THP-1 cell population with impaired
mitochondrial activity (deﬁned as a MitoTracker Red ﬂuorescence intensity <2000 a.u.). (C) PL intensity per well following incubation with various
treatments containing CN-PPV. Values represent the mean standard deviation from n¼ 3 experiments with diﬀerent THP-1 passage numbers.
15262 | RSC Adv., 2017, 7, 15255–15264 This journal is © The Royal Society of Chemistry 2017
RSC Advances Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
7 
M
ar
ch
 2
01
7.
 D
ow
nl
oa
de
d 
on
 0
9/
11
/2
01
7 
11
:5
4:
43
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
colours by tuning the particle size, and characterized by large
absorption cross-sections (some 100 fold that of uorescent
dyes), large Stokes' shis, narrow emission bands (FWHM20–
40 nm) and minimal photobleaching.25 Qdots serve as the
imaging ‘gold standard’ at which all other probes can be
measured; however, their toxicity is a major drawback in terms
of their applications. Many groups are exploring new synthesis
methods to address this major drawback by replacing highly
toxic heavy metal cadmium with less toxic zinc or indium or by
surrounding the quantum dots in polymers that are biocom-
patible.26 Another property of Qdots which set them aside is
their chemical stability and fabrication into nearly any desired
monodisperse size, which other nanoparticle imaging systems
have yet to match. CPNs on the other hand have even higher
absorption cross sections and brighter emission proles than
Qdots of similar size, whilst being easy to fabricate and modify
for a variety of applications.1–5
CPNs that possess strong, stable optical properties in the
NIR window, that are produced by methods easy to scale up for
industrial manufacturing, and that exhibit positive biocom-
patibility attributes, such as low toxicity, long circulation times
and biodegradability, will be more suitable for clinical trans-
lation.27 These design features have driven the current study
investigating the performance and biocompatibility of PLGA–
PEG : CN-PPV CPNs both with and without incorporation of low
molecular weight NIR dyes.
A moderately high molecular weight PEG5 kDa–PLGA55 kDa
with a 50 : 50 blend of lactic and glycolic acid was chosen
because it was hypothesized that a higher percentage of the
relatively more hydrophobic PLGA component would achieve
a higher encapsulation eﬃciency of the CN-PPV and NIR dyes.28
Further, it was hypothesized that the longer PLGA chains would
stabilise an elongated, rather than coiled, conformation of the
CN-PPV, thus resulting in an improved optical performance.29,30
The high surface density of the 5 kDa PEG chain will also
provide a protective corona around the self-assembled polymer
shell.31 Detailed studies are currently underway to investigate
the mechanism and rate of biodegradation under biologically
relevant conditions.
The use of CN-PPV was inspired by a recent report from Ye
et al.3 who described a CPN system comprised of CN-PPV,
highlighting the excellent optical properties of a related
system when processed into nanoparticle form due to its
intrinsic chain stability through polymer chain aggregation
rather than single chain emission.3,32–34 The electronegativity of
the cyano-moieties also results in a certain amphiphilicity of the
polymer chain, which enables CN-PPV to self-assemble into
moderately stable colloidal structures upon injection into
aqueous media. These diﬀerences help explain the enhanced
luminescence quantum yield, photostability, and colloidal
stability for CN-PPV versus other conjugated polymers.
An important outcome of this study was the observation that
encapsulation of very small amounts of CN-PPV as low as 5% (m
m1) in PLGA–PEG polymeric micelles enhances the optical
performance and stability of the systems over long time frames.
The QY of CN-PPV alone (0 : 1) was found to be high at 37%, but
was 3–8% higher in the 20 : 1 systems. The QY values obtained
for the PLGA–PEG : CN-PPV nanoparticles are slightly lower
than CN-PPV in solvent (50%) but higher than most lms
(30%).32–34 Incorporation of a small molecule NIR-emitting dye
resulted in even higher QY values with 38% and 45% for 20 : 1
(680) and 20 : 1 (720), respectively. These values can be
considered high when compared against the FDA approved dye
indocyanine green with a QY of <1%.24 Of further note, the
extremely eﬃcient FRET transfer in 20 : 1 (720) system
produced an extremely narrow FWHM at 23 nm. This is of
particular interest for diagnostic applications and is more than
twice as narrow as the commercially available NIR quantum
dots, such as Qdot®705 (ref. 35) (70 nm) and other promising
experimental NIR emitting polymer nanoparticles.1–11
Following optical performance, the manufacturability and in
vivo safety of novel nanodiagnostics will be twomajor hurdles in
the path towards clinical translation. The utilisation of PLGA–
PEG to form a self-assembling vehicle for the conjugated poly-
mer serves to address some requirements of clinical trans-
lation.27,28 The closely related, PEG-PLA (poly ethylene-glycol-co-
poly lactic acid) block copolymers have been used in clinical
trials (Genexol-PM® or Cynviloq™).28 These copolymers are
highly biocompatible and semi-biodegradable, providing
a mechanism for elimination of the nanodiagnostic from the
body over time.
Currently, there are no known biodegradation mechanisms
for conjugated polymer nanoparticles, although encapsulation
of these inert polymers within a matrix of biodegradable
copolymer can greatly reduce the mass of conjugated polymer
in the CPN system, while enhancing the optical performance.
This lower burden of conjugated polymer may improve in vivo
safety proles of such systems. It should be noted that a number
of studies have already shown an excellent cyto-compatibility
prole across a range of CPNs.23,36–38 However, long term
studies investigating in vivo safety are still outstanding.
Finally, the simple self-assembly of PLGA–PEG into polymer
micelles following injection of the polymer solution into an
aqueous phase, combined with the eﬃcient encapsulation of
CN-PPV within the micelle core, result in a manufacturing
process with a high yield (>90%) and very reproducible product
characteristics. Furthermore, the manufacture of self-
assembling CPNs lends itself to semi-continuous
manufacturing practices and the potential for easy scale up
from lab to commercial batch sizes even with the stringent
quality requirements for injectable diagnostic products.
Conclusions
Clinical translation of novel optical nanodiagnostics requires
not only optimisation of optical performance, but also the
design of systems with suitable safety and manufacturability
characteristics. This study demonstrated that the encapsulation
of the red-emitting conjugated polymer, CN-PPV, within poly-
mer micelles comprised of the biodegradable diblock copol-
ymer, PLGA–PEG, resulted in a system with excellent optical
properties and the possibility of further translation towards
clinical applications. Concurrent encapsulation of the hydro-
phobic small molecular weight NIR dye, NIR720, produced an
This journal is © The Royal Society of Chemistry 2017 RSC Adv., 2017, 7, 15255–15264 | 15263
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optimised system with a small hydrodynamic diameter, narrow
emission peak at 720 nm, a very high quantum yield of 45% and
an excellent biocompatibility compared with related systems.
Further studies will focus on assessment of the targeting
capabilities of the optimised systems, as well as in vivo safety
and performance.
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